In HFpEF, adding empagliflozin to usual care reduced a composite of CV death or HF hospitalization at a median 26 mo.
Where this comes from
- Record sourced from PubMed, PMID 34978853.
- Also identified by DOI 10.7326/J21-0006.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Anker SD, Butler J, Filippatos G, et al. <b>Empagliflozin in heart failure with a preserved ejection fraction.</b> N Engl J Med. 2021;385:1451-61. 34449189.
Medical subject headings
- Heart Failure